New phase 2 data from personalized cancer vaccine EVX-01 demonstrates a record-high rate of vaccine targets triggering a tumor-specific immune responseThe results reinforce that Evaxion’s pioneering ...
Firebird, a U.S.-based AI cloud and infrastructure company, announced Phase Two of its AI supercomputing megaproject, securing U.S. export licensing and regulatory approvals for the sale and delivery ...
The next leg of the artificial intelligence (AI) boom won't be flashy, but it might be where the smartest money is quietly ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...
Executives are hyping their AI adoption rates like it's their quarterly revenue. Over the past 90 days, CEOs have referenced "early AI adopters" at least 60 times in earnings calls, conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results